Carmen Gómez-Guerrero

13PUBLICATIONS
22CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyMedical biochemistry - lipidsHaematological tumoursNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 28, 2026
Alirocumab Attenuated Plaque Inflammation and PCSK9-Induced Proinflammatory Signalling in M1 Macrophages Independently of Lipid Lowering.

Cristina Espadas, Manuel Soto-Catalán, María Romero-Cote

|Mar 14, 2026
SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob.

Marcelo Aguilar-Cartes, Lucas Opazo-Ríos, Alejandra Droguett

|Mar 13, 2024
Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease.

Manuel Soto-Catalán, Lucas Opazo-Ríos, Hernán Quiceno

|Dec 23, 2022
The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice.

Luna Jiménez-Castilla, Lucas Opazo-Ríos, Gema Marin-Royo

|Dec 24, 2021
Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy.

Luna Jiménez-Castilla, Gema Marín-Royo, Macarena Orejudo

|Jul 29, 2021
Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development.

Laura Lopez-Sanz, Susana Bernal, Luna Jimenez-Castilla

Pageof 3

Frequent Collaborators

7 joint publications

Lucas Opazo-Ríos

4 joint publications

Juan Antonio Moreno

3 joint publications

Sebastian Mas-Fontao

2 joint publications

Jesús Egido